PYODERMA

Clinical trials for PYODERMA explained in plain language.

Never miss a new study

Get alerted when new PYODERMA trials appear

Sign up with your email to follow new studies for PYODERMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a psoriasis drug heal these stubborn skin ulcers?

Disease control Recruiting now

This study tests guselkumab (Tremfya), a drug already used for psoriasis, in 17 adults with pyoderma gangrenosum—a rare disease that leads to painful, hard-to-heal skin ulcers. Participants receive injections every 4 weeks for 28 weeks. Researchers will check if ulcers heal compl…

Matched conditions: PYODERMA

Phase: PHASE2 • Sponsor: Oregon Health and Science University • Aim: Disease control

Last updated Jun 27, 2026 09:10 UTC

PYODERMA

Get alerted when new PYODERMA trials appear

Can a psoriasis drug heal these stubborn skin ulcers?